NEETPGAI
FeaturesNEET PGFMGEINI-CETBlogPricing
Log inStart Free
NEETPGAI

AI-powered NEET PG preparation platform. Master all 19 subjects with adaptive MCQs, AI tutoring, and spaced repetition.

Product

  • Features
  • Subjects
  • Previous Year Questions
  • NEET PG Preparation
  • FMGE Preparation
  • INI-CET Preparation
  • Compare
  • Pricing
  • Blog

Features

  • Adaptive MCQ Practice
  • AI Tutor
  • Mock Tests
  • Spaced Repetition

Resources

  • Blog
  • Study Guides
  • NEET PG Updates
  • Contact & support

Legal

  • Privacy Policy
  • Terms of Service

Stay updated

© 2026 NEETPGAI. All rights reserved.
    Subjects/Medicine/Heart Failure
    Heart Failure
    hard
    stethoscope Medicine

    A 72-year-old woman from Mumbai with a 10-year history of hypertension and diabetes presents with progressive dyspnea, fatigue, and ankle swelling for 6 weeks. On examination: BP 145/92 mmHg, HR 88/min regular, JVP 6 cm, no S3 gallop, lungs clear to auscultation bilaterally. Echocardiography shows LVEF 52%, LV wall thickness 14 mm, LA enlargement, and restrictive mitral inflow pattern (E/A ratio 2.2, E/e' ratio 14). Which of the following is the most likely diagnosis?

    A. Acute decompensated heart failure due to acute coronary syndrome
    B. Restrictive cardiomyopathy secondary to amyloidosis
    C. Diastolic heart failure with preserved ejection fraction (HFpEF)
    D. Systolic heart failure with reduced ejection fraction (HFrEF)

    Explanation

    Clinical Presentation Analysis

    Key Diagnostic Features
    Table
    FeatureFindingSignificance
    LVEF52%≥ 50% = Preserved EF
    LV Wall Thickness14 mmIncreased (normal < 11 mm); suggests LVH
    LA EnlargementPresentChronic elevation of LV filling pressures
    Mitral Inflow PatternE/A = 2.2 (E > A)Restrictive/impaired relaxation pattern
    E/e' Ratio14≥ 14 indicates elevated LV filling pressures
    S3 GallopAbsentArgues against systolic HF
    Lung AuscultationClearNo pulmonary edema clinically
    Risk FactorsHTN, DM × 10 yearsClassic for diastolic dysfunction

    Diagnosis: HFpEF (Diastolic Heart Failure)

    Key Point
    This patient meets diagnostic criteria for heart failure with preserved ejection fraction (HFpEF), also called diastolic heart failure:
    1. 1.
      Symptoms and signs of HF (dyspnea, fatigue, ankle edema, elevated JVP)
    2. 2.
      LVEF ≥ 50% (preserved systolic function)
    3. 3.
      Evidence of diastolic dysfunction:
      • Restrictive mitral inflow (E/A > 1 in restrictive pattern)
      • Elevated E/e' ratio (≥ 14 = elevated LV filling pressure)
      • LA enlargement (chronic pressure overload)
      • LVH (from chronic hypertension)
    High-YieldNEET PG
    HFpEF accounts for 40–50% of all HF cases, particularly in elderly women with hypertension and diabetes. The diagnosis requires both clinical HF symptoms AND evidence of diastolic dysfunction on echo.

    Pathophysiology of HFpEF

    Loading diagram...
    Clinical Pearl
    In HFpEF, the problem is NOT weak contraction (systolic function is normal) but STIFF ventricles that don't relax well (diastolic dysfunction). This explains why inotropes and ACE-I have limited benefit.

    Why Other Options Are Incorrect

    Option 1: HFrEF
    • LVEF is 52% (≥ 50%), which is preserved, not reduced
    • HFrEF is defined as LVEF ≤ 40%; this patient's EF is normal
    • No S3 gallop (typical in HFrEF)
    • Trap: Some students confuse "heart failure" with "reduced EF" — HFpEF is equally common
    Option 3: Restrictive Cardiomyopathy (Amyloidosis)

    While the restrictive mitral inflow pattern (E/A > 1) might suggest restriction, several features argue against primary restrictive cardiomyopathy:

    • LVH pattern (14 mm wall thickness) is typical of hypertensive LVH, not amyloidosis
    • Risk factors (HTN, DM) point to secondary diastolic dysfunction, not primary myocardial disease
    • No systemic symptoms (no weight loss, neuropathy, hepatomegaly mentioned)
    • LA enlargement alone is common in HFpEF from HTN; it is not specific for amyloidosis
    • Amyloidosis typically presents with biventricular involvement, conduction abnormalities, and low voltage on ECG (not mentioned here)
    Warning
    Restrictive cardiomyopathy is a diagnosis of exclusion; it requires ruling out secondary causes (HTN, infiltrative disease) first.
    Option 4: Acute Decompensation from ACS
    • No acute presentation (6-week gradual onset, not acute chest pain)
    • No ECG changes or troponin elevation mentioned
    • HR is regular at 88/min (no arrhythmia)
    • No acute coronary risk profile described
    • This is a chronic, progressive picture, not acute decompensation

    Diagnostic Criteria for HFpEF (ESC 2021)

    All three required:

    1. 1.
      Symptoms ± signs of HF
    2. 2.
      LVEF ≥ 50%
    3. 3.
      At least one of:
      • Elevated natriuretic peptides (BNP > 35 pg/mL or NT-proBNP > 125 pg/mL)
      • Diastolic dysfunction on echo (E/e' ≥ 14, LA volume index > 34 mL/m²)
      • Elevated LV filling pressures on catheterization

    Mnemonic for HFpEF Features: "STIFF Ventricle"

    • Systolic function normal (EF ≥ 50%)
    • Thick walls (LVH from HTN)
    • Impaired relaxation (E/A > 1 in restrictive pattern)
    • Filling pressures elevated (E/e' ≥ 14)
    • Functional limitation (dyspnea, fatigue)

    Management Implications

    Key Point
    HFpEF management differs from HFrEF:
    • No mortality benefit from ACE-I, beta-blockers, or aldosterone antagonists (unlike HFrEF)
    • Diuretics for symptom relief
    • BP control (target < 130/80 mmHg)
    • Treat comorbidities (HTN, DM, AF)
    • SGLT2 inhibitors (empagliflozin, dapagliflozin) show promise in recent trials
    • Avoid excessive diuresis (preload-dependent in diastolic dysfunction)

    Practice similar questions

    Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.

    Start Practicing Free More Medicine Questions

    Join our NEET PG community

    Daily MCQs, study tips, and topper strategies on Telegram.

    Join on Telegram →